✦ LIBER ✦

In vivo inhibition of CYP2C19 but not CYP2D6 by fluvoxamine

✍ Scribed by ZHEN-HUA XU; HONG-GUANG XIE; HONG-HAO ZHOU

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dose-dependent inhibition of CYP1A2, CYP

✍ U. Jeppesen; L. F. Gram; K. Vistisen; S. Loft; H. E. Poulsen; K. Brøsen 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 95 KB

Relationship between fluvoxamine pharmac

✍ O. Spigset; K. Granberg; S. Hägg; Å. Norström; R. Dahlqvist 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 155 KB

Polymorphism of CYP2D6, CYP2C19, CYP2C9

✍ Jónrit Halling; Maria S. Petersen; Per Damkier; Flemming Nielsen; Philippe Grand 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 290 KB

Chlorpropamide 2-hydroxylation is cataly

✍ Ji-Hong Shon; Young-Ran Yoon; Min-Jung Kim; Kyoung-Ah Kim; Young-Chae Lim; Kwang 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

The pharmacokinetics of ketobemidone are

✍ Ayman Al-Shurbaji; Juliette Säwe 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 84 KB

Fluvoxamine inhibits the CYP2C19-catalys

✍ B. Buur Rasmussen; T. L. Nielsen; K. Brøsen 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 108 KB